Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

Cresco Labs Clears US Antitrust Hurdle in Proposed Acquisition of Columbia Care.

Document Cited in Related
Vincent

MANews-(C)2009-2022

The 30-day waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 has passed in connection with US-based cannabis company Cresco Labs Inc's (CSE: CL) (OTCQX: CRLBF) proposed acquisition of Columbia Care Inc. (NEO: CCHW) (CSE: CCHW) (OTCQX: CCHWF) (FSE:3LP), the company said.

On March 23, 2022, Cresco Labs announced the execution of a definitive arrangement agreement to acquire all of the issued and outstanding shares of Columbia Care.

The closing of the transaction remains subject to the satisfaction of all remaining closing conditions in the agreement, including the Columbia Care shareholder vote.

Both companies say they continue to work towards obtaining all required regulatory approvals.

Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States.

Employing a consumer-packaged goods approach, Cresco Labs is the largest wholesaler of branded cannabis products in the US.

Its brands are designed to meet the needs of various consumer segments and comprised of some of the most recognized and trusted national brands including Cresco, High Supply, Mindy's Edibles, Good News, Remedi, Wonder Wellness Co. and FloraCal Farms.

Sunnyside, Cresco Labs' national dispensary brand, is a wellness-focused retailer created to build trust, education...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT